Guillain-Barré syndrome.

Prim Care

2300-A Manchester Expressway, Suite 201, Columbus, GA 31903, USA.

Published: June 2015

Guillain-Barré syndrome and its clinical variants are a group of rapidly progressing, potentially debilitating neurologic disorders that may have significant morbidity/mortality if left unrecognized or untreated. The most common symptoms include ascending limb weakness and paralysis, which may progress to respiratory failure. Diagnosis is made clinically with laboratory testing. Several treatment options exist, including plasma exchange and intravenous immunoglobulin administration. Most cases may resolve without sequelae, but those that do not may leave behind significant persistent debility.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pop.2015.01.001DOI Listing

Publication Analysis

Top Keywords

guillain-barré syndrome
8
syndrome guillain-barré
4
syndrome clinical
4
clinical variants
4
variants group
4
group rapidly
4
rapidly progressing
4
progressing debilitating
4
debilitating neurologic
4
neurologic disorders
4

Similar Publications

Very long-term remission with azacitidine in VEXAS syndrome.

Haematologica

January 2025

Université Paris Cité, Assistance Publique des Hôpitaux de Paris (APHP) Nord, Hôpital Saint-Louis, Hématologie Seniors, Paris, France; Université Paris Cité, INSERM UMR 944, Institut de Recherche Saint-Louis, Paris.

Not available.

View Article and Find Full Text PDF

Objectives: This study aimed to identify clinical features of girls referred to a pediatric endocrinology clinic for suspected precocious puberty, differentiate true precocious puberty from other variants, evaluate treatment status, and identify distinguishing factors between patient groups.

Methods: We retrospectively evaluated the records of 275 consecutive girls aged 0-10 years referred for suspected precocious puberty.

Results: Among the patients, 30 (10.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!